More Treatment, but Not Less Anxiety and Mood Disorders: Why? Seven Hypotheses and Their Evaluation
- PMID: 36746121
- PMCID: PMC10273873
- DOI: 10.1159/000528544
More Treatment, but Not Less Anxiety and Mood Disorders: Why? Seven Hypotheses and Their Evaluation
Keywords: Common mental disorder; Counterproductive effects; Population-level impact of treatment; Treatment gaps.
Conflict of interest statement
All authors report no financial interests or potential conflicts of interest.
References
-
- Vigo D, Thornicroft G, Atun R. Estimating the true global burden of mental illness. Lancet Psychiatry. 2016 FEB;3((2)):171–178. - PubMed
-
- Baxter AJ, Scott KM, Ferrari AJ, Norman RE, Vos T, Whiteford HA. Challenging the myth of an “epidemic” of common mental disorders: trends in the global prevalence of anxiety and depression between 1990 and 2010. Depress Anxiety. 2014 Jun 2014;31((6)):506–516. - PubMed
-
- Richter D, Wall A, Bruen A, Whittington R. Is the global prevalence rate of adult mental illness increasing? Systematic review and meta-analysis. Acta Psychiatr Scand. 2019;140((5)):393–407. - PubMed
-
- Ferrari AJ, Somerville AJ, Baxter AJ, Norman R, Patten SB, Vos T, et al. Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med. 2013 Mar;43((3)):471–481. - PubMed
